Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?

Alexander Jordan, Pradeesh Sivapalan, Jens-Ulrik Jensen

Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alexander Jordan, Pradeesh Sivapalan, Jens-Ulrik Jensen. Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?. Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Inhaled beta2-agonists and death for asthma: can we overcome this risk?
Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths
Year: 2007

Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020

Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020

Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?
Source: Eur Respir J 2011; 37: 1-3
Year: 2011

Is GLCCI1 associated with response to inhaled corticosteroids in asthma patients?
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012

How can we minimise the use of regular oral corticosteroids in asthma?
Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Year: 2020

Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?
Source: Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018
Year: 2019

Does combination therapy lead to better adherence in asthma?
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010

Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Inhaled corticosteroids reduce growth. Or do they?
Source: Eur Respir J 2001; 17: 287-294
Year: 2001

Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study
Source: Eur Respir J, 54 (6) 1900901; 10.1183/13993003.00901-2019
Year: 2019

Does the treatment with inhaled steroids or long acting β-2-agonists prevent LRTIs?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009

Mild asthma. Is constant therapy by inhaled steroids necessary?
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019

Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics
Source: Eur Respir J 2001; 17: 380-385
Year: 2001

Is beta-agonist alone prescribed in case of uncontrolled asthma?
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

The risk of mycobacterial infections associated with inhaled corticosteroid use
Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017
Year: 2017

Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis
Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020
Year: 2021